Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.66EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
BA.5.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
FH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.98EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.90EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
FB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.18.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.26.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
FK.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used